Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin plus emotion recognition training in residential male youth with antisocial behavior
2019-001910-40Phase 2Active
- Sponsor
- Radboud University
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in antisocial personality disorder (ASPD) (2 arms), sponsored by Radboud University. Primary endpoint: Change in emotion recognition accuracy. Started Jun 2020; status: active.
02
Drugs
oxytocin
03
Conditions
antisocial personality disorder (ASPD)
Beyond the preview
Go deeper on 2019-001910-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001910-40.